RESI Europe 2019 Innovation Challenge – Check Out the Winners

28 Mar

By Claire Jeong, Director of Research, Asia BD, LSN


On Monday, March 25th, companies from North America, Western Europe, Israel, etc. showcased their technologies in the Vienna Marriott Hotel exhibition hall, where LSN organized the first ever (and quite successful!) RESI Europe conference. As usual, conference attendees were provided with 5 pieces of “RESI Cash” which they could use to “invest” in the companies of their choice. Again, congratulations to all finalists who were selected to present, and we hope RESI was able to serve as a great venue for creating valuable connections. But most importantly, we are excited to announce the Top 3 winners of this Innovation Challenge – please check their details below!

First Place: Rx Bandz

Rx Bandz provides a game-changing, cost-effective solution for millions of people globally who need to carry emergency injectable medication. Nearly 60% of them do not carry their prescribed auto-injectors with them. MiniJect,™ our miniaturized auto-injector, delivers a wide range of injectable drugs. Its small size and intuitive design make it easy to carry and simple to use. The first drug delivery platform for epinephrine will allow active patients to take it with them, thus increasing compliance and saving lives. Our world-class team has designed and tested a medical device that is also an attractive accessory. We have been deemed eligible for FDA- 505(B)2, the expedited pathway to market.  We have the options of either licensing the device for multiple medications, or taking it to market. Accessory attachments to the MiniJect,™ offer yet another revenue stream.

Jessica Walsh, Founder & CEO, Rx Bandz


Second Place: PhotoPill Medical

PhotoPill Medical develops a revolutionary state-of-the-art disposable swallow-able capsule for treating Crohn’s disease flare-ups and as a preventive treatment in-between flares, by implementing Photo-Bio-Modulation treatment (PBMt) and gut microbiota modulation light-protocols as it travels through the intestine. The PhotoPill capsule is personalized for each patient based on disease location and individual peristaltic rate. Photopill’s unique disruptive technology would be a first of its kind for intestinal tissue treatment and gut bacteria related disorders. This would be a safe, easy to use, cost effective solution for a huge market and a painful problem. PhotoPill has demonstrated excellent pre-clinical results, and preliminary data in IBD Proctitis patients, using Photopill’s dedicated rectal device. PhotoPill has strong IP portfolio and strong and experienced team.

Sharon Ben Yehuda, Co-Founder, PhotoPill Medical


Third Place: Pathfinder Medical

Pathfinder Medical is developing a novel electronic catheter guidance system that will enable clinicians to connect blood vessels in a minimally invasive way. This platform technology has a variety of clinical applications in peripheral vascular and dialysis procedures, together representing a €4.5 billion yearly market. Open surgery is the current standard for preparing patients for dialysis and bypassing blocked peripheral arteries. High failure rates (approximately 50%) in both cases present a serious danger to life and require repeat procedures, for US dialysis patients alone this adds up to $4.6 billion per year. The ePATH catheter platform aims to eliminate need for open surgery in several vascular procedures, improving outcomes and reducing the burden on patients and healthcare systems.

Sorin Popa, Founder & CEO, Pathfinder Medical

If you missed out on the opportunity to compete in the RESI Europe Innovation Challenge, we would be happy to take your applications for our upcoming RESI Philadelphia on Monday, June 3rd. Please visit our online application portal at to get your application started!

Now Offering RESI Philadelphia Early Bird Rates

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: